A Jolt to the System: Biohaven Shares Stumble Following a Pivotal Analyst Call

The Shifting Sands of Biotech: Wall Street Zen Taps Puma Biotech's Roar Down a Notch

Immunocore at the Crossroads: Steady Hands and the Search for Tomorrow's Breakthrough

Wall Street Whispers: Unpacking the Latest Analyst Shifts for Phathom Pharmaceuticals

The Curious Case of Catalyst Pharma: Cash-Rich, But What Comes Next?

Sana Biotech Skyrockets: Eric Jackson's Bold Endorsement Fuels 50% Surge

Unlocking Monopar's Potential: A Speculative Bet on Imminent Cancer Breakthroughs